Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.67
-0.36 (-5.12%)
Jun 27, 2025, 4:00 PM - Market closed
Wave Life Sciences Employees
As of December 31, 2024, Wave Life Sciences had 288 total employees, including 287 full-time and 1 part-time employees. The number of employees increased by 20 or 7.46% compared to the previous year.
Employees
288
Change (1Y)
20
Growth (1Y)
7.46%
Revenue / Employee
$364,372
Profits / Employee
-$390,028
Market Cap
1.03B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WVE News
- 7 days ago - Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Wave Life Sciences Ltd. (WVE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 - GlobeNewsWire
- 3 months ago - Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 - Seeking Alpha
- 3 months ago - Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year - Benzinga